Literature DB >> 3732924

Establishment and characterization of two human ovarian endometrioid carcinoma cell lines (with or without squamous cell component).

I Ishiwata, C Ishiwata, M Soma, H Ishikawa.   

Abstract

The cell lines designated HMOA and HNOA were established from human ovarian adenoacanthoma and from a mouse graft of human ovarian endometrioid adenocarcinoma, respectively. These cell lines grew well without interruption for over 20 months. The cultured cells of both HMOA and HNOA lines were spindle, polygonal, and columnar, and showed a jigsaw puzzle-like arrangement and a piling-up tendency devoid of contact inhibition. When the HMOA cells were maintained at the confluent stage, the cells formed cysts and/or squamous metaplasia. The chromosome number of both cell lines varied widely and showed aneuploidy, while the modal chromosome number was stable at the diploid range. Both of these cell lines, HMOA and HNOA, were transplanted into the subcutis of BALB/c nude mice and produced well-differentiated adenoacanthoma and poorly differentiated endometrioid adenocarcinoma, respectively. HMOA cells were characterized as producing large amounts of CA125 (ovarian carcinoma marker), in vitro, in the cyst-forming phase. The HNOA cells, however, did not produce CA125.

Entities:  

Mesh:

Year:  1986        PMID: 3732924     DOI: 10.1016/0090-8258(86)90070-3

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  7 in total

1.  Production of various marker substances in human ovarian cancer cell lines of epithelial origin.

Authors:  S Sekiya; N Tanaka; H Takamizawa
Journal:  Arch Gynecol Obstet       Date:  1990       Impact factor: 2.344

2.  Development of new immunoradiometric assay for CA 125 antigen using two monoclonal antibodies produced by immunizing lung cancer cells.

Authors:  M Kunimatsu; K Endo; T Nakashima; T Awaji; T Saga; Y Watanabe; Y Kawamura; H Ohta; M Koizumi; H Sakahara
Journal:  Ann Nucl Med       Date:  1988-11       Impact factor: 2.668

3.  Involvement of the MDR1 gene and glycolipids in anticancer drug-resistance of human ovarian carcinoma-derived cells.

Authors:  Kyoko Tanaka; Kazushige Kiguchi; Mikio Mikami; Daisuke Aoki; Masao Iwamori
Journal:  Hum Cell       Date:  2019-07-26       Impact factor: 4.174

4.  Correlation between expression of oncogene products and resistance to anticancer drugs in cultured ovarian cancer cell lines.

Authors:  Yoshiaki Okuma; Kazushige Kiguchi; Yutaka Koshitaka; Asami Okamura; Isamu Ishiwata; Haruhiro Kondo; Bunpei Ishizuka; Mamoru Tadokoro
Journal:  Hum Cell       Date:  2003-09       Impact factor: 4.174

5.  Establishment and characterization of a cell line (NOMH-1) originating from a human endometrioid adenocarcinoma of the ovary.

Authors:  Takashi Yamada; Takayoshi Kanda; Hiroshi Mori; Kaname Shimokawa; Mitsuo Kagawa; Yuro Shibayama
Journal:  J Ovarian Res       Date:  2013-02-04       Impact factor: 4.234

6.  Characterisation of seven human ovarian tumour cell lines.

Authors:  A P Wilson; M Dent; T Pejovic; L Hubbold; H Radford
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

7.  Expression of vascular endothelial growth factor and E-cadherin in human ovarian cancer: association with ascites fluid accumulation and peritoneal dissemination in mouse ascites model.

Authors:  Noriyuki Akutagawa; Akira Nishikawa; Masahiro Iwasaki; Takashi Fujimoto; Mizue Teramoto; Yoshimitsu Kitajima; Toshiaki Endo; Masabumi Shibuya; Ryuichi Kudo
Journal:  Jpn J Cancer Res       Date:  2002-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.